🇺🇸 FDA
Patent

US 8324203

Azadecalin glucocorticoid receptor modulators

granted A61PA61P1/00A61P11/06

Quick answer

US patent 8324203 (Azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P11/06, A61P17/02, A61P19/02